Rima A. Mohammad, PharmD, BCPS, FCCP

Clinical Pharmacy Specialist- Post ICU and Hepatology
Clinical Associate Professor in Clinical Pharmacy
Rotation(s) Offered: Academia, Post-ICU Recovery Multidisciplinary Clinic, Hepatology Telemedicine Clinic
rimam@umich.edu
Articles ↓

Biography

Rima Mohammad is Clinical Associate Professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy and clinical pharmacist in gastrointestinal diseases and post-ICU recovery at Michigan Medicine.

Pharmacy School Attended: University of Cincinnati (2004)

Other Training:

  • PGY1 Pharmacy: University of Michigan (2005)
  • PGY2 Critical Care: University of Michigan (2006)

Areas of Interest

Areas of research interest include: infectious disease, gastroenterology/hepatology, and critical care. Scholarly work has focused on post-ICU recovery, especially focused on clinical outcomes, clinical services and patient care models.

Honors & Awards

  • 2020: PDC Faculty Appreciation Award –P3 class
  • 2019: University of Michigan College of Pharmacy Teaching Excellence Award nominee
  • 2018: Sepsis Heroes Award –Sepsis Alliance
  • 2016: Fellow of the American College of Clinical Pharmacy (FCCP)
  • 2015: ACCP Adult Medicine PRN MeRIT program tuition scholarship 
  • 2012: American Society of Health-System Pharmacists (ASHP) and American Pharmacists Association (APhA) Top 10 Finalist for best practices in Medication Management in Care Transitions
  • 2012: ACCP Best Poster Top 8 Finalist
  • 2012: Jewish Healthcare Foundation Fine Award Finalist
  • 2012: ACCP Adult Medicine PRN Best Poster
  • 2007: ACCP Spring Practice and Research Forum Best Resident and Fellow Poster
  • 2005: ACCP Economics and Outcomes PRN project acknowledgement
  • 2003: Ohio Society of Health-Systems Pharmacists Student Award

Published Articles or Reviews

  • Smith MA, Chan J, Mohammad RA. Ledipasvir-sofosbuvir: interferon-/ribavirin-free regimen for chronic hepatitis C virus infection. Ann Pharmacother. 2015 Mar;49(3):343-350.
  • Smith MA, Mohammad RA. Invited commentary: Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof of concept phase 2a cohort study. Lancet Infect Dis. 2015 Sep;15(9):993-5
  • Smith MA, Love BL, Mohammad RA. The changing landscape of adverse drug eventsassociated with chronic hepatitis C virus therapy. Expert Opin Drug Saf. 2015 Nov;14(11):1649-52.
  • Smith MA, Regal RE, Mohammad RA. Daclatasvir: A NS5A replication complex inhibitor for hepatitis C infection. Ann Pharmacother. 2016 Jan;50(1):39-46.
  • Deming P, Martin MT, Chan J, Dilworth TJ, El-Lababidi R, Love BL, Mohammad RA, Nguyen A, Spooner LM, Wortman SB. Therapeutic advances in HCV genotype 1 infection: insights from the society of infectious diseases pharmacists. Pharmacotherapy. 2016 Feb;36(2):203-17.
  • DiPaula B, Mohammad RA, Ayers P, Basalyga V, Burton A, Bush C, Farthing K, Marshall V, Shah B. Residents as preceptors and education: what we can learn from a national survey to improve our residency programs. Currents in Pharmacy Teaching and Learning. Curr Pharm Teach Learn. 2018 Jan -Feb;10(1):21-27.
  • Coe AB, Bookstaver RE, Fritschle AC, Kenes MT, MacTavish P, Mohammad RA, Simonelli RJ, Whitten JA, Stollings JL. (2019) Pharmacists’ perceptions on their role, activities, facilitators, and barriers to practicing in a post-intensive care recovery clinic. Hospital Pharmacy. https://doi.org/10.1177/0018578718823740
  • Mohammad RA, Ellingrod VL, Bleske BE. Implementing and evaluating virtual patient cases within a team‐based learning pedagogy in a therapeutics course sequence. JACCP. 2019; 2(2);143-149.
  • McConachie SM, Claudia MH, Raub JN, Mohammad RA, Wilhelm SM. The impact of multiple renal estimates on pharmacist dosing recommendations: a randomized trial. Ann Pharmacother. 2020 Jun 24;1060028020935447. doi: 10.1177/1060028020935447.
  • Sabourin AA, Fisher-Grant KK, Saulles AR, Mohammad RA. Evaluation of a specialty hepatitis c virus pharmacy service. Am J Health Syst Pharm. 2020 (in press)
  • Mohammad RA, Regal RE. Viral Hepatitis C. In Terry Schwinghammer, Julia Koehler: Pharmacotherapy Casebook: A Patient-Focused Approach, 9th ed. 2015.
  • Mohammad RA, Regal RE. Viral Hepatitis C. In Terry Schwinghammer, Julia Koehler: Pharmacotherapy Casebook: A Patient-Focused Approach, 10th ed. 2017.
  • Mohammad RA. Inflammatory Bowel Disease. In: ACCP Pharmacotherapy Self-Assessment Program (PSAP), 2020, Book 2: Pulmonary and Gastroenterology. 2020.